About Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle
"L’Institut du Cancer de Montpellier (ICM) est le centre de référence en Occitanie-Est, reconnu au niveau national pour son expertise et son innovation dans la prise en charge et le traitement des patients atteints de cancers : cancer du sein, cancers digestifs (colon, rectum, pancréas…), cancers gynécologiques (col de l’utérus, ovaires…), cancer de la prostate, cancer du poumon, sarcomes, cancer ORL... La prise en charge et l’accompagnement des patients atteints de cancer à Montpellier et dans toute la région est assurée par des équipes médicales pluridisciplinaires spécialisées. Il regroupe des unités de soins, de prévention, de recherche clinique, translationnelle et fondamentale en cancérologie. L’ICM fait partie du réseau UNICANCER."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Institut du Cancer de Montpellier - Val d'Aurelle
99
UNICANCER
74
Hoffmann-La Roche
24
Institut Claudius Regaud
20
ARCAGY/ GINECO GROUP
18
European Organisation for Research and Treatment of Cancer - EORTC
17
Centre Oscar Lambret
16
Centre Leon Berard
15
Institut Cancerologie de l'Ouest
10
Pfizer
8
Centre Francois Baclesse
6
Clinical Trials at Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle
During the past decade, Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle conducted 260 clinical trials. In the 10-year time frame, 260 clinical trials started and 27 clinical trials were completed, i.e. on
average, 10.4% percent of trials that started reached the finish line to date. In the past 5 years, 80 clinical trials started and 17 clinical trials were completed. i.e. 21.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer
1994-12-01
2002-01-01
Completed
180
Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus
1996-10-01
2010-08-01
Completed
250
Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer
1997-12-01
2015-01-01
Completed
450
Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Advanced Cancer of the Oropharynx or Hypopharynx
1998-10-01
2011-01-01
Completed
160
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
1999-01-04
2007-03-31
Completed
350
Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer
1998-10-01
2001-03-01
Terminated
160
Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer
1998-03-01
2002-04-01
Completed
40
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors
1998-03-01
2000-03-01
Terminated
45
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle" #1 sponsor was "Institut du Cancer de Montpellier - Val d'Aurelle" with 99 trials, followed by "UNICANCER" with 74 trials
sponsored, "Hoffmann-La Roche" with 24 trials sponsored, "Institut Claudius Regaud" with 20 trials sponsored and "ARCAGY/ GINECO GROUP"
with 20 trials sponsored. Other sponsors include 211 different institutions and
companies that sponsored additional 90 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle"
#1 collaborator was "AstraZeneca" with 20 trials as a collaborator, "National Cancer Institute, France" with 14 trials as a collaborator, "Merck Sharp & Dohme LLC" with 9 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 8 trials as a collaborator and "Hoffmann-La Roche" with 8 trials as a collaborator. Other collaborators include 312 different institutions and companies that were
collaborators in the rest 212 trials.
Clinical Trials Conditions at Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle
According to Clinical.Site data, the most researched conditions in "Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle" are
"Breast Cancer" (70 trials), "Colorectal Cancer" (23 trials), "Prostate Cancer" (23 trials), "Ovarian Cancer" (19 trials) and "Cancer" (16 trials). Many other conditions were trialed in "Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle" in a lesser frequency.
Clinical Trials Intervention Types at Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle
Most popular intervention types in "Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle" are "Drug" (284 trials), "Other" (78 trials), "Procedure" (73 trials), "Radiation" (64 trials) and "Biological" (43 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (27 trials), "fluorouracil" (25 trials), "radiation therapy" (22 trials), "Paclitaxel" (21 trials) and "Bevacizumab" (18 trials). Other intervention names were less common.
Clinical Trials Genders at Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle
The vast majority of trials in "Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle" are
297 trials for "All" genders, 121 trials for "Female" genders and 32 trials for "Male" genders.
Clinical Trials Status at Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle
Currently, there are NaN active trials in "Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle".
2 are not yet recruiting,
119 are recruiting,
82 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 192 completed trials in Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle,
5 suspended trials,
and 28 terminated clinical trials to date.
Out of the total trials that were conducted in Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle, 43 "Phase 1"
clinical trials were conducted, 152 "Phase 2" clinical
trials and 134 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 6 trials, and there were
also 101 trials that are defined as “Not Applicable".